ImmunityBio - Stock Price History | IBRX

Historical daily share price chart and data for ImmunityBio since 2021 adjusted for splits. The latest closing stock price for ImmunityBio as of September 27, 2021 is 10.67.
  • The all-time high ImmunityBio stock closing price was 42.25 on February 22, 2021.
  • The ImmunityBio 52-week high stock price is 45.42, which is 325.7% above the current share price.
  • The ImmunityBio 52-week low stock price is 6.80, which is 36.3% below the current share price.
  • The average ImmunityBio stock price for the last 52 weeks is 15.68.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
ImmunityBio Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 7.5886 3.9600 17.6100 2.6000 13.3300 251.72%
2019 1.3395 1.3000 3.8400 0.9990 3.7900 226.72%
2018 3.3776 4.3800 5.3100 1.0100 1.1600 -74.16%
2017 5.0401 5.9100 8.1900 2.8300 4.4900 -21.50%
2016 7.8181 15.7500 15.7500 5.6900 5.7200 -66.99%
2015 17.7575 34.6400 34.9900 10.6600 17.3300 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.167B $0.000B
ImmunityBio Inc. is a late-clinical-stage immunotherapy company developing therapies which drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems. ImmunityBio Inc., formerly known as NantKwest Inc., is based in CULVER CITY, Calif.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29